Literature DB >> 16081293

8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities.

Ainura Chodoeva1, Jean-Jacques Bosc, Jean Guillon, Alain Decendit, Michel Petraud, Christelle Absalon, Christiane Vitry, Christian Jarry, Jacques Robert.   

Abstract

A new alkaloid of Aconitum karacolicum Rapcs, from the Ranunculaceae family, collected in Kirghizstan, was isolated from the roots of this plant, using a purification scheme based upon its in vitro antiproliferative properties against three human tumour cell lines in culture. Structural identification was performed using high resolution MS-MS mass spectrometry and (1)H, (13)C, 2D NOESY NMR spectroscopy analysis. This compound consists of a 14-benzoylaconine moiety substituted on C-8 by an azeloyl chain. It presents in vitro cytotoxicity with an IC(50) of about 10-20 microM, which warrants further investigation on its possible interest in cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081293     DOI: 10.1016/j.bmc.2005.07.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Cytotoxic esterified diterpenoid alkaloid derivatives with increased selectivity against a drug-resistant cancer cell line.

Authors:  Koji Wada; Emika Ohkoshi; Susan L Morris-Natschke; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2011-11-11       Impact factor: 2.823

2.  Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents.

Authors:  Koji Wada; Emika Ohkoshi; Yu Zhao; Masuo Goto; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2015-02-18       Impact factor: 2.823

Review 3.  Aconiti Lateralis Radix Praeparata as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms.

Authors:  Wen Zhang; Chaoying Lu; Shuhui Cai; Yaru Feng; Jinjun Shan; Liuqing Di
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

4.  Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells.

Authors:  Koji Wada; Masaharu Hazawa; Kenji Takahashi; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  J Nat Med       Date:  2010-08-14       Impact factor: 2.343

5.  Antitumor activity of semisynthetic derivatives of Aconitum alkaloids.

Authors:  Ainura Chodoeva; Jean-Jacques Bosc; Lydia Lartigue; Jean Guillon; Céline Auzanneau; Pierre Costet; Ashiraly Zurdinov; Christian Jarry; Jacques Robert
Journal:  Invest New Drugs       Date:  2013-06-13       Impact factor: 3.850

6.  Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth.

Authors:  Masaharu Hazawa; Koji Wada; Kenji Takahashi; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2008-06-13       Impact factor: 3.850

Review 7.  Two decades of advances in diterpenoid alkaloids with cytotoxicity activities.

Authors:  Xiaoxia Liang; Yingying Gao; Shangxian Luan
Journal:  RSC Adv       Date:  2018-07-02       Impact factor: 4.036

Review 8.  Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon ( Shén Nóng Běn Cǎo Jīng).

Authors:  Kuo-Hsiung Lee; Susan Morris-Natschke; Keduo Qian; Yizhou Dong; Xiaoming Yang; Ting Zhou; Eileen Belding; Shou-Fang Wu; Koji Wada; Toshiyuki Akiyama
Journal:  J Tradit Complement Med       Date:  2012-01

Review 9.  Anticancer Activities of C18-, C19-, C20-, and Bis-Diterpenoid Alkaloids Derived from Genus Aconitum.

Authors:  Meng-Yue Ren; Qing-Tian Yu; Chun-Yu Shi; Jia-Bo Luo
Journal:  Molecules       Date:  2017-02-13       Impact factor: 4.411

10.  Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors.

Authors:  Lingyue Zhao; Qian Yang; Yiqun Tang; Qidong You; Xiaoke Guo
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.